Does Rallies show 13F holders for VANI?

Yes. Rallies tracks hedge fund and 13F ownership data for VANI, including fund names, share counts, latest tracked quarter, and position changes when available.

Is VANI research on Rallies investment advice?

No. Rallies provides research, data, and educational context for VANI. It does not provide personalized investment advice.

VANI (Vivani Medical, Inc. Common Stock (DE)) Stock Analysis - Hedge Fund Holdings

Vivani Medical, Inc. Common Stock (DE) (VANI) is a publicly traded Healthcare sector company. As of May 21, 2026, VANI trades at $1.19 with a market cap of $98.31M and a P/E ratio of -2.73. VANI moved +3.48% today. Year to date, VANI is -5.56%; over the trailing twelve months it is +3.48%. Its 52-week range spans $0.91 to $1.92. Analyst consensus is buy with an average price target of $3.75. Rallies surfaces VANI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns VANI stock?

Hedge funds tracked by Rallies that own VANI include Panagora Asset. The latest tracked quarter is Sep 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Vivani Medical, Inc. Common Stock (DE).

VANI Key Metrics

Key financial metrics for VANI
Metric	Value
Price	$1.19
Market Cap	$98.31M
P/E Ratio	-2.73
EPS	$-0.43
Dividend Yield	0.00%
52-Week High	$1.92
52-Week Low	$0.91
Volume	0
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-26.61M
Gross Margin	0.00%

Top Hedge Funds Holding VANI

Panagora Asset holds 19.48K shares of VANI, changed +0.00% as of Sep 30, 2025.

Latest VANI News

Vivani Medical Secures $28M Cash Runway as SLIM-1 Trial Kicks Off Mid-2026 — May 13, 2026
Vivani Medical’s NPM-139 Shows >20% Weight Loss, Phase 1 Starts Mid-2026 — Mar 26, 2026

Recent VANI Insider Trades

Williams Gregg bought 1.59M (~$2.00M) on May 15, 2026.
Williams Gregg bought 1.59M (~$2.00M) on Apr 15, 2026.
Williams Gregg bought 1.31M (~$1.35M) on Mar 15, 2026.

VANI Analyst Consensus

2 analysts cover VANI: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $3.75.

Common questions about VANI

Who owns VANI stock?: Hedge funds tracked by Rallies that own VANI include Panagora Asset. The latest tracked quarter is Sep 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Vivani Medical, Inc. Common Stock (DE).
Does Rallies show 13F holders for VANI?: Yes. Rallies tracks hedge fund and 13F ownership data for VANI, including fund names, share counts, latest tracked quarter, and position changes when available.
Is VANI research on Rallies investment advice?: No. Rallies provides research, data, and educational context for VANI. It does not provide personalized investment advice.